NJSの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/07/28 | 1,356 | 1,362 | 1,354 | 1,357 | +2 | +0.1% | 6,900 |
2017/07/27 | 1,367 | 1,367 | 1,355 | 1,355 | -12 | -0.9% | 5,200 |
2017/07/26 | 1,370 | 1,374 | 1,363 | 1,367 | -4 | -0.3% | 4,400 |
2017/07/25 | 1,372 | 1,379 | 1,370 | 1,371 | -1 | -0.1% | 8,700 |
2017/07/24 | 1,372 | 1,372 | 1,370 | 1,372 | ±0 | ±0% | 4,200 |
2017/07/21 | 1,370 | 1,372 | 1,365 | 1,372 | +2 | +0.1% | 6,100 |
2017/07/20 | 1,360 | 1,372 | 1,354 | 1,370 | -1 | -0.1% | 5,300 |
2017/07/19 | 1,373 | 1,373 | 1,364 | 1,371 | +7 | +0.5% | 3,700 |
2017/07/18 | 1,363 | 1,371 | 1,360 | 1,364 | +1 | +0.1% | 6,600 |
2017/07/14 | 1,368 | 1,368 | 1,350 | 1,363 | -5 | -0.4% | 3,800 |
2017/07/13 | 1,372 | 1,372 | 1,366 | 1,368 | +1 | +0.1% | 2,100 |
2017/07/12 | 1,373 | 1,373 | 1,364 | 1,367 | -1 | -0.1% | 4,500 |
2017/07/11 | 1,372 | 1,372 | 1,368 | 1,368 | +4 | +0.3% | 1,500 |
2017/07/10 | 1,374 | 1,374 | 1,364 | 1,364 | +1 | +0.1% | 7,900 |
2017/07/07 | 1,377 | 1,377 | 1,363 | 1,363 | -3 | -0.2% | 2,200 |
2017/07/06 | 1,374 | 1,374 | 1,364 | 1,366 | -8 | -0.6% | 1,900 |
2017/07/05 | 1,365 | 1,374 | 1,365 | 1,374 | +9 | +0.7% | 3,900 |
2017/07/04 | 1,375 | 1,375 | 1,365 | 1,365 | -11 | -0.8% | 2,300 |
2017/07/03 | 1,374 | 1,378 | 1,373 | 1,376 | +2 | +0.1% | 2,300 |
2017/06/30 | 1,381 | 1,381 | 1,372 | 1,374 | -8 | -0.6% | 4,300 |
2017/06/29 | 1,383 | 1,383 | 1,372 | 1,382 | -1 | -0.1% | 6,100 |
2017/06/28 | 1,380 | 1,388 | 1,379 | 1,383 | -10 | -0.7% | 5,900 |
2017/06/27 | 1,396 | 1,396 | 1,385 | 1,393 | +4 | +0.3% | 4,000 |
2017/06/26 | 1,395 | 1,395 | 1,386 | 1,389 | +11 | +0.8% | 5,700 |
2017/06/23 | 1,383 | 1,384 | 1,376 | 1,378 | -8 | -0.6% | 6,800 |
2017/06/22 | 1,394 | 1,397 | 1,385 | 1,386 | +6 | +0.4% | 2,600 |
2017/06/21 | 1,392 | 1,392 | 1,380 | 1,380 | -13 | -0.9% | 3,100 |
2017/06/20 | 1,395 | 1,397 | 1,382 | 1,393 | +11 | +0.8% | 5,000 |
2017/06/19 | 1,375 | 1,386 | 1,375 | 1,382 | -7 | -0.5% | 7,200 |
2017/06/16 | 1,385 | 1,391 | 1,385 | 1,389 | +4 | +0.3% | 1,700 |
2017/06/15 | 1,386 | 1,393 | 1,385 | 1,385 | ±0 | ±0% | 2,900 |
2017/06/14 | 1,388 | 1,398 | 1,385 | 1,385 | -7 | -0.5% | 3,500 |
2017/06/13 | 1,390 | 1,402 | 1,390 | 1,392 | +7 | +0.5% | 2,900 |
2017/06/12 | 1,389 | 1,389 | 1,385 | 1,385 | -4 | -0.3% | 5,800 |
2017/06/09 | 1,385 | 1,390 | 1,385 | 1,389 | +7 | +0.5% | 3,900 |
2017/06/08 | 1,400 | 1,400 | 1,382 | 1,382 | -14 | -1% | 11,100 |
2017/06/07 | 1,392 | 1,396 | 1,392 | 1,396 | +1 | +0.1% | 3,100 |
2017/06/06 | 1,394 | 1,403 | 1,394 | 1,395 | +1 | +0.1% | 3,000 |
2017/06/05 | 1,398 | 1,406 | 1,388 | 1,394 | -13 | -0.9% | 46,200 |
2017/06/02 | 1,408 | 1,411 | 1,403 | 1,407 | -1 | -0.1% | 3,400 |
2017/06/01 | 1,404 | 1,433 | 1,396 | 1,408 | +12 | +0.9% | 21,200 |
2017/05/31 | 1,406 | 1,406 | 1,396 | 1,396 | -8 | -0.6% | 8,600 |
2017/05/30 | 1,400 | 1,404 | 1,397 | 1,404 | +4 | +0.3% | 1,900 |
2017/05/29 | 1,388 | 1,401 | 1,388 | 1,400 | +13 | +0.9% | 2,700 |
2017/05/26 | 1,400 | 1,400 | 1,387 | 1,387 | -9 | -0.6% | 3,000 |
2017/05/25 | 1,399 | 1,399 | 1,392 | 1,396 | +4 | +0.3% | 3,800 |
2017/05/24 | 1,398 | 1,398 | 1,382 | 1,392 | -5 | -0.4% | 8,000 |
2017/05/23 | 1,391 | 1,400 | 1,391 | 1,397 | +6 | +0.4% | 3,200 |
2017/05/22 | 1,400 | 1,401 | 1,388 | 1,391 | +1 | +0.1% | 3,800 |
2017/05/19 | 1,391 | 1,394 | 1,385 | 1,390 | -9 | -0.6% | 5,500 |
1751~
1800
件表示中 / 5390件
類似銘柄と比較する
現在ご覧いただいている「NJS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NJS | 350,000円 | +2.2% | +73.1% | 2.71% | 15.86倍 | 1.25倍 |
|
上下水道のコンサルタント。官公需がほとんど。調査から設計・施工監理まで一貫。海外拠点多数 |
WDB | 175,900円 | +5.1% | -13.4% | 3.44% | 11.63倍 | 1.15倍 |
|
理学系研究職や研究補助職の人材派遣で首位。医薬品開発受託(CRO)や医薬関連事務も |
ITM | 167,300円 | +7.9% | +3.1% | 5.98% | 20.79倍 | 3.31倍 |
|
IT系ネットメディア運営。各種広告展開。営業見込み客情報提供するリードジェンを強化中 |
クリーク&リバ | 150,800円 | +10.4% | +16.0% | 2.85% | 10.29倍 | 2.05倍 |
|
テレビ・ゲーム・Web・広告等の派遣、制作が主。医療ほか専門職分野拡大。配当性向30%メド |
アイロムG | 278,500円 | - | - | - | - | 2.64倍 |
|
SMO(医療機関向け治験支援)主力。日・豪でCRO(医薬品開発受託)。MBO実施準備 |
市場注目の銘柄
チャート関連のコラム